UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000017092
Receipt number R000019824
Scientific Title Phase 1 dose-escalation, safety / tolerability and preliminary efficacy study of intratumoral and subcutaneous administration of GEN0101 in patients with recurrence of castration resistant prostate cancer
Date of disclosure of the study information 2015/04/15
Last modified on 2017/10/18 18:10:38

No. Disposal Last modified on Item of update
1 Insert 2015/04/09 23:12:08
2 Update 2015/05/20 15:30:39 Key inclusion criteria
Key exclusion criteria
3 Update 2015/05/20 15:44:36 Division name
Name of person sending information
Name of person sending information
Address
Address
TEL
Email
Institute
4 Update 2015/05/20 16:09:49 Organization
Organization
Category of Funding Organization
Nationality of Funding Organization
Nationality of Funding Organization
Co-sponsor
Co-sponsor
Institutions
5 Update 2015/05/20 16:12:25 Institutions
6 Update 2015/05/20 16:51:24 Interventions/Control_1
Interventions/Control_1
7 Update 2015/06/15 11:08:04 Recruitment status
Anticipated trial start date
8 Update 2016/10/09 18:46:29 Name of primary person or sponsor
Institute
Institute
Organization
Organization
9 Update 2016/10/09 18:52:52 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
10 Update 2017/04/10 10:36:46 Organization
Organization
Division name
Division name
TEL
11 Update 2017/04/18 17:31:47 Name of person sending information
Name of person sending information
TEL
Email
12 Update 2017/10/11 16:34:41 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
13 Update 2017/10/18 18:10:38 Recruitment status